Literature DB >> 3572462

Time-dose factors in chemotherapy: expanding the concept of dose-intensity.

A J Dembo.   

Abstract

Mesh：

Substances：

Year:  1987        PMID： 3572462     DOI： 10.1200/JCO.1987.5.5.694

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  5 in total

1.  Dose intensity of carboplatin in combination with cyclophosphamide or ifosfamide.

Authors:  J A Green; K Smith
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

2.  Febrile neutropenic events in cancer patients: treatment for fever and neutropenia in young adult patients during intensive chemotherapy for solid tumours.

Authors:  M Nobbenhuis; F J Cleton
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

3.  A trial of individual dose intensity and relative performance factors in tegafur maintenance chemotherapy for head and neck cancer.

Authors:  S Sawaki; H Watanabe; T Shin; T Kubota; S Komiyama; T Umezaki; I Nahm
Journal:  Eur Arch Otorhinolaryngol       Date:  1993       Impact factor: 2.503

4.  The effect of intensity of administered treatment on the outcome of germ cell tumours treated with POMB/ACE chemotherapy.

Authors:  S M Crawford; E S Newlands; R H Begent; G J Rustin; K D Bagshawe
Journal:  Br J Cancer       Date:  1989-02       Impact factor: 7.640

5.  Outcome in stage III non-Hodgkin's lymphoma in children (UKCCSG study NHL 86)--how much treatment is needed? United Kingdom Children's Cancer Study Group.

Authors:  C R Pinkerton; I Hann; O B Eden; M Gerrard; J Berry; M G Mott
Journal:  Br J Cancer       Date:  1991-09       Impact factor: 7.640
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.